4A/4B, Peptide (1)

Control peptide version of dynamin inhibitory peptide, myristoylated, an inhibitor of the GTPase dynamin that competitively blocks binding of dynamin to amphiphysin, preventing endocytosis. In contrast to dynamin inhibitory peptide, has no significant effect on GABAA receptor-mediated miniature IPSPs.

Parimifasor（LYC-30937-EC，LYC30937）是一种口服生物可利用的肠溶 ATP 酶调节剂，作为肠道定向疗法用于治疗炎症性肠病 (IBD)。